Phenylephrine Hemorrhoidal Suppository
NDC Package 13709-330-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Phenylephrine Hemorrhoidal (hemorrhoidal suppositories) suppositories is • Adults: when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipe. This formulation utilizes a suppository delivery system. Marketed by Neilmed Pharmaceuticals Inc., this product is identified by NDC 13709-330 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
13709-330-01
Package Description
30 BLISTER PACK in 1 CARTON / 2 g in 1 BLISTER PACK
Product Code
11-Digit Billing Format
13709033001
RxNorm Crosswalk
  • RxCUI: 2715398 - phenylephrine hydrochloride 0.25 % Rectal Suppository
  • RxCUI: 2715398 - phenylephrine hydrochloride 0.0025 MG/MG Rectal Suppository

Clinical Specifications

Proprietary Name
Phenylephrine Hemorrhoidal
Non-Proprietary Name
Hemorrhoidal Suppositories
Substance Name
Phenylephrine Hydrochloride
Dosage Form
Suppository - A solid body of various weights and shapes, adapted for introduction into the rectal orifice of the human body; they usually melt, soften, or dissolve at body temperature.
Administration Route
Rectal - Administration to the rectum.
Usage Information
• Adults: when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipe. Gently dry by patting or blotting with a tissue or a soft cloth before insertion of this product. • Detach one suppository from the strip; remove the foil wrapper as shown in the illustration • Insert one suppository into the rectum pointed end first, up to 4 times daily, especially at night, in the morning or after each bowel movement.

Regulatory & Marketing

Labeler Name
Neilmed Pharmaceuticals Inc.
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-23-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (13709-330). Click a package code to view its specific billing and regulatory data.

15 BLISTER PACK in 1 CARTON / 2 g in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 13709-330-01 identifies a specific commercial package of 30 blister pack in 1 carton / 2 g in 1 blister pack of Phenylephrine Hemorrhoidal, a human over the counter drug labeled by Neilmed Pharmaceuticals Inc.. This suppository is formulated for rectal use and contains phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Neilmed Pharmaceuticals Inc. on May 23, 2025. The current certification is valid through December 31, 2026.

How is this Neilmed Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 13709033001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
13709-330-01
11-Digit CMS (5-4-2)
13709-0330-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.